Follow the 듀켐바이오 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 듀켐바이오 has recorded 39 insider filings. The latest transaction was reported on 27 December 2024 (Purchase). Among the most active insiders: 김종우. All data is openly available.
39
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
n/a
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
듀켐바이오 is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on developing innovative biopharmaceutical solutions.